Regulatory and pipeline updates from Regeneron (REGN) and Incyte (INCY), among others, have been in focus in the biotech industry over the past week. Find out more at https://ift.tt/3mWiWll via Entrepreneur.com

Read more of this post


This free site is ad-supported. Learn more